39 Crown Resources: Integration Of Commitment Has Paid Off Over Is Expected To B
Since listing, the debt crisis has been plagued 39 Medicine Through a series of asset integration, and finally among the Chinese people to see the pharmaceutical industry benchmarking company hopes not only to express its 2009 results beat expectations, the company name was formally crown “CR”, which further established enterprises in central China Resources Department as Pharmacy Industrial integration platform due status.
SW study also pointed out that the 2009 CR 39 to achieve earnings per share 0.72 yuan, 0.66 yuan more than they expected before. 2010, as Essential drugs system Step by step, expected 39 stomach Taihe Is Pill Growth will accelerate, San Jiu Wei Tai in 2012 to 600 million yuan in revenue. Biochemistry 2009, its subsidiary toad income has reached about 100 million yuan, is expected to continue in 2010 increased by 40% to 50%. In addition, the 2010 CR 39 will also actively buy OTC and herbal prescription drug companies, by a good brand and variety into the 39 Sell System to realize the extension-extension.
This, Galaxy Securities analyst Li Ying Peng pharmaceutical industry believe that Traditional Chinese Medicine as the controlling shareholder of the new 39 39 Holdings Limited (now renamed as China Resources Medical Holdings Limited) has pledged the company in share reform implemented, if the results of operations can not achieve set targets, tradable shareholders will get shares recover 1. In reality, the company in 2008, 2009, earnings per share were 0.51 yuan and 0.72 yuan, exceeding the 2008 basic earnings per share not less than 0.50 yuan / share, the year 2009 not less than 0.65 yuan / unit commitment,
buy mbt shoes, the controlling shareholders will not have to send shares of catching.
Some analysts have pointed out that CR 39 and renamed-than-expected annual results, indicating China Resources Group 39 medicine in recent years, especially 2009, debts of assets, consolidation, capital injection, has achieved initial success,
mbt anti shoe, however, 2010 Resources 39 years for 30%, though still expected to achieve faster growth, but to maintain growth performance in 2009 or there is a certain degree of difficulty.
The above analysis,
monster beats, SW medical analysts believe that completion of the restructuring, China Resources 39 results are ultra-year market forecast, the current valuation of CR 39 has a margin of safety, therefore, to give 35 times 2010 forecast earnings, target price raised to 31.2 yuan, maintaining overweight rating.
2 24, 39 Pharmaceutical Co., Ltd. officially changed to CRC 39 Pharmaceutical Company Limited (the “CR 39″), a day earlier announced its results for the 2009 Express-than-expected and due to be completed the share reform commitments,
nike air force sale, the closely watched, given the major brokers have recommended rating.
39 Medicine published results of Letters in 2009 showed that in 2009 the company achieved operating income of 4.853 billion yuan,
hollister outlet, up 12.43 percent; operating profit of 885 million yuan, up 39.37%; net profit of 709 million yuan, an increase of 1.86%, earnings per share of 0.72 yuan.
I am an expert from China Manufacturers, usually analyzes all kind of industries situation, such as dior eye glasses , cartier eyeglass frames.
Than-expected performance of commitment to complete share reform
topics related articles：
sennheiser - 104 RBI hogan world - they’ womens timberland shoes - Bench and hand vices for watch work shops While watch repair is being carried out, it is necessary to hold watch parts in place. Bench vices are tools to hold intricate watch components in place while working on them. Hand vices let the worker hold the subject with a firmer grip and hold the subject closer to the eyes for better inspection.
